Clinical trial
Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus…
NCT00308425 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00308425 |
|---|---|
| Title | Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS |
| Official title | Effect of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Valsartan as Part of Intensified Multi-factorial Intervention Compared to EC-MPS Plus Standard Practice of Care on Development of Transplant Nephropathy in Cadaver Donor Kidney Recipients Given Basiliximab, Cyclosporine Microemulsion… |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | De Novo Renal Transplantation |
| Intervention type | Drug |
| Interventions | Enteric-coated Mycophenolate sodium (EC-MPS), valsartan |
| Enrollment | 119 |
| Start date | Oct 1, 2002 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Mar 29, 2006 |
| Last update posted | Jan 31, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: